| Issuer | % of Class | Filed |
|---|---|---|
|
Nautilus Biotechnology, Inc.
13D/A
Amendment 2
NAUT · 63909J108
|
17.6% |
3/4/2026
Event 3/2/2026
|
|
Nautilus Biotechnology, Inc.
13D/A
Amendment 1
NAUT · 63909J108
|
17.4% |
3/5/2025
Event 3/3/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.